Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR3 | P49019 | 3/20 | 0.59 |
| ▸ | SLC9A1 | P19634 | 5/20 | 0.55 |
| ▸ | CNR1 | P21554 | 3/20 | 0.51 |
| ▸ | ACHE | P22303 | 3/20 | 0.51 |
| ▸ | CNR2 | P34972 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MGAM | O43451 | 1/20 | 0.44 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | SI | P14410 | 1/20 | 0.44 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | RIPK1 | Q13546 | 2/20 | 0.43 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.43 |
| ▸ | CDK9 | P50750 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | NSD2 | O96028 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19911532 | 0.92 | HCAR3 (0.57) | HCAR3SLC9A1CNR1ACHECNR2 | |
| SCHEMBL19911556 | 0.89 | SLC9A1 (0.55) | HCAR3SLC9A1CNR1ACHECNR2 | |
| SCHEMBL19911535 | 0.86 | HCAR3 (0.55) | HCAR3SLC9A1ALDH1A1MGAMAMY1A | |
| SCHEMBL19911541 | 0.86 | HCAR3 (0.46) | HCAR3SLC9A1CNR1ACHECNR2 | |
| SCHEMBL19911568 | 0.82 | KCNH2 (0.46) | HCAR3SLC9A1CNR1ACHECNR2 | |
| SCHEMBL19911553 | 0.81 | SLC9A1 (0.53) | HCAR3SLC9A1CNR1ACHECNR2 | |
| SCHEMBL19911537 | 0.80 | ALDH1A1 (0.47) | ALDH1A1MGAMAMY1AGAASI | |
| SCHEMBL19911547 | 0.80 | ALDH1A1 (0.44) | HCAR3ALDH1A1MGAMAMY1AGAA | |
| SCHEMBL3474345 | 0.80 | ALDH1A1 (0.44) | HCAR3ALDH1A1MGAMAMY1AGAA | |
| SCHEMBL210082 | 0.78 | NSD2 (0.61) | HCAR3SLC9A1ALDH1A1MAPTNSD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180062213-A1 | Nonaqueous Electrolyte and Nonaqueous Secondary Battery | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2018-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180062213-A1 | Nonaqueous Electrolyte and Nonaqueous Secondary Battery | BPTF, BRD4, KCNN2 | HCAR3 4636/4885SLC9A1 341/4885CNR1 3847/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.